Inflammasome-dependent dysfunction and death of retinal ganglion cellsafter repetitive intraocular pressure spikes. Cells. 2023, Nov 15;12(22):2626.

 

Neural-Cardiac Inflammasome Axis After Traumatic Brain Injury. Pharmaceuticals (Basel). 2023 Sep 28;16(10):1382.

 

 

Prognostic and Diagnostic Utility of Serum Biomarkers in Pediatric Traumatic Brain Injury. J Neurotrauma. 2023 Aug 30.

 

Methods to Study Inflammasome Activation in the Central Nervous System: Immunoblotting and Immunohistochemistry. Methods Mol Biol. 2023;2696:223-238.

 

Utility of Brain Injury Biomarkers in Children with Congenital Heart Disease Undergoing Cardiac Surgery. Pediatric Neurology. July 6. 2023. Review.

 

Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease. Pharmaceuticals (Basel). 2023 Jun 15;16(6):883.

​

​

Sex Differences in the Inflammatory Profile in the Brain of Young and Aged Mice. Cells. 2023, 12(10), 1372.

 

Inflammasome Signaling Proteins as Biomarkers of COVID-19. Frontiers in Immunology. 2023 Apr 24;14:1014665.

 

Importance of Timing Optimization for Closed-Loop Applications of Vagus Nerve Stimulation. Bioelectronic Medicine. 2023 Apr 27;9(1):8.

 

Activation of inflammasomes and their effects on neuroinflammation at the microelectrode-tissue interface in intracortical implants. Biomaterials. 2023 Mar 28;297:122102.

​

Genetic Predisposition to Alzheimer’s Disease Alters Inflammasome Activity After Traumatic Brain Injury. Translational Research. 2023 Feb 7.